Literature DB >> 19483732

Medical oncology: Multimodality therapy in unresectable colorectal cancer.

Daniel A Popowich1, Amy L Halverson.   

Abstract

Mathis et al. aimed to determine the effect of multimodality therapy on recurrence and survival in patients with locally advanced colorectal cancer. Use of multimodality treatment led to excellent local control with five year disease-free and overall survival rates comparable to that of stage-matched resectable colorectal cancers.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19483732     DOI： 10.1038/nrclinonc.2009.65

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


  7 in total

Review 1.  Role of radiotherapy with surgery for T3 and resectable T4 rectal cancer: evidence from randomized trials.

Authors:  Cecile Ortholan; Eric Francois; Olivier Thomas; Daniel Benchimol; Jacques Baulieux; Jean F Bosset; Jean P Gerard
Journal:  Dis Colon Rectum       Date:  2006-03       Impact factor: 4.585

Review 2.  What is the role for the circumferential margin in the modern treatment of rectal cancer?

Authors:  Iris D Nagtegaal; Phil Quirke
Journal:  J Clin Oncol       Date:  2008-01-10       Impact factor: 44.544

3.  Population-based assessment of the surgical management of locally advanced colorectal cancer.

Authors:  Anand Govindarajan; Natalie G Coburn; Alex Kiss; Linda Rabeneck; Andrew J Smith; Calvin H L Law
Journal:  J Natl Cancer Inst       Date:  2006-10-18       Impact factor: 13.506

4.  Multivisceral resection for colon cancer.

Authors:  Pedro Luna-Pérez; Saúl E Rodríguez-Ramírez; Marcos Gutiérrez De la Barrera; Moisés Zeferino; Sonia Labastida
Journal:  J Surg Oncol       Date:  2002-06       Impact factor: 3.454

5.  Cancer statistics, 2008.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Taylor Murray; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2008-02-20       Impact factor: 508.702

Review 6.  State of the art and recent advance in the treatment of resectable nonmetastatic rectal cancer.

Authors:  C Ortholan; J P Gerard; K Benezery; E Francois
Journal:  Surg Oncol       Date:  2007-11-26       Impact factor: 3.279

7.  Predictors of multivisceral resection in patients with locally advanced colorectal cancer.

Authors:  Anand Govindarajan; Novlette Fraser; Vanessa Cranford; Debrah Wirtzfeld; Steve Gallinger; Calvin H L Law; Andrew J Smith; Anna R Gagliardi
Journal:  Ann Surg Oncol       Date:  2008-05-13       Impact factor: 5.344
  7 in total
  2 in total

1.  RNA-seq identifies determinants of oxaliplatin sensitivity in colorectal cancer cell lines.

Authors:  Xin-Xiang Li; Jun-Jie Peng; Lei Liang; Li-Yong Huang; Da-Wei Li; De-Bing Shi; Hong-Tu Zheng; San-Jun Cai
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  RNA-seq reveals determinants for irinotecan sensitivity/resistance in colorectal cancer cell lines.

Authors:  Xin-Xiang Li; Hong-Tu Zheng; Jun-Jie Peng; Li-Yong Huang; De-Bing Shi; Lei Liang; San-Jun Cai
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.